Trial intelligence / Profile preview

Predictors of Clomiphene Response in PCOS

NCT02269306Completed

Sponsor
Menoufia Obstetrics and Gynecology Group
Start
Jan 2011
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of clomiphene in polycystic ovary syndrome (PCOS), sponsored by Menoufia Obstetrics and Gynecology Group. Primary endpoint: First ovulation with CC at 3 months. Started Jan 2011; status: completed.

02

Drugs

clomiphene
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02269306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02269306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call